Considering the concept of quality as a degree of excellence, the term quality of laboratory work tells us how excellent our results are in all areas of laboratory work. Therefore, quality indicators have been introduced with the aim of monitoring and measuring quality. Quality indicators describe the efficiency of the laboratory process in the form of a numerical value, providing objective evidence of the conformity of the specified laboratory process with respect to predefined criteria. The Working Group for Postanalytics of the Croatian Society of Medical Biochemistry and Laboratory Medicine has decided to describe the necessary steps in designing and monitoring quality indicators, with an emphasis on the quality of the postanalytical and post-postanalytical phase. The main purpose of these recommendations is to facilitate the incorporation of quality indicators into laboratories' daily routines. Laboratories in the Republic of Croatia are recommended to monitor three quality indicators in the postanalytical phase of laboratory work: turnaround time, withdrawn or retracted laboratory test reports, and notification of critical results. Additionally, two indicators are recommended in the post-postanalytical phase: monitoring issuance of laboratory test reports and monitoring user satisfaction. Harmonising acceptable performance limits and monitoring of the most commonly used quality indicators opens up the possibility of comparisons between laboratories and a uniform quality of laboratory services throughout the healthcare system.
{"title":"National recommendations of the Working Group for Postanalytics of the Croatian Society of Medical Biochemistry and Laboratory Medicine: Quality indicators of the postanalytical phase.","authors":"Sonja Podolar, Jelena Vlašić Tanasković, Anja Jokić, Lorena Honović, Vladimira Rimac, Jasna Leniček Krleža","doi":"10.11613/BM.2026.010503","DOIUrl":"https://doi.org/10.11613/BM.2026.010503","url":null,"abstract":"<p><p>Considering the concept of quality as a degree of excellence, the term quality of laboratory work tells us how excellent our results are in all areas of laboratory work. Therefore, quality indicators have been introduced with the aim of monitoring and measuring quality. Quality indicators describe the efficiency of the laboratory process in the form of a numerical value, providing objective evidence of the conformity of the specified laboratory process with respect to predefined criteria. The Working Group for Postanalytics of the Croatian Society of Medical Biochemistry and Laboratory Medicine has decided to describe the necessary steps in designing and monitoring quality indicators, with an emphasis on the quality of the postanalytical and post-postanalytical phase. The main purpose of these recommendations is to facilitate the incorporation of quality indicators into laboratories' daily routines. Laboratories in the Republic of Croatia are recommended to monitor three quality indicators in the postanalytical phase of laboratory work: turnaround time, withdrawn or retracted laboratory test reports, and notification of critical results. Additionally, two indicators are recommended in the post-postanalytical phase: monitoring issuance of laboratory test reports and monitoring user satisfaction. Harmonising acceptable performance limits and monitoring of the most commonly used quality indicators opens up the possibility of comparisons between laboratories and a uniform quality of laboratory services throughout the healthcare system.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"36 1","pages":"010503"},"PeriodicalIF":1.8,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12912737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146222165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute pancreatitis is a potentially life-threatening complication of severe hypertriglyceridemia. The accurate measurement of triglyceride concentration is essential for diagnosis and therapeutic monitoring. This article presents a case of acute hypertriglyceridemia pancreatitis in which the patient's triglyceride concentration appeared to drop rapidly from 128.04 mmol/L to 1.53 mmol/L within 12 hours of admission. Subsequent retesting revealed an actual triglyceride value of 88.92 mmol/L. This case underscores a critical and underreported preanalytical challenge: the failure of the analyzer to trigger "> Kin" warnings despite clear abnormalities in the reaction kinetics curve, leading to clinically significant underestimation. To mitigate such errors, we propose a novel strategy that integrates automated lipemic index-based predilution protocols with enhanced alarm configurations, including the introduction of a ">Abs" alert, adjustment of prozone detection parameters, and the implementation of correlation checks between lipemic indices and triglyceride values within the laboratory information system. These practical interventions, which can be adopted in clinical laboratories, represent a proactive approach to prevent erroneous reporting and enhance diagnostic reliability. This report highlights the necessity for increased vigilance among laboratory professionals when discordance occurs between high lipemic indices and unexpectedly low triglyceride results, suggesting possible kinetic anomalies.
{"title":"Falsely decreased triglyceride concentration in a patient with acute pancreatitis due to insufficient configuration of alarm rules.","authors":"Yin Liu, Qianhui Liu, Bin Feng, Wei Gan","doi":"10.11613/BM.2026.011002","DOIUrl":"https://doi.org/10.11613/BM.2026.011002","url":null,"abstract":"<p><p>Acute pancreatitis is a potentially life-threatening complication of severe hypertriglyceridemia. The accurate measurement of triglyceride concentration is essential for diagnosis and therapeutic monitoring. This article presents a case of acute hypertriglyceridemia pancreatitis in which the patient's triglyceride concentration appeared to drop rapidly from 128.04 mmol/L to 1.53 mmol/L within 12 hours of admission. Subsequent retesting revealed an actual triglyceride value of 88.92 mmol/L. This case underscores a critical and underreported preanalytical challenge: the failure of the analyzer to trigger \"> Kin\" warnings despite clear abnormalities in the reaction kinetics curve, leading to clinically significant underestimation. To mitigate such errors, we propose a novel strategy that integrates automated lipemic index-based predilution protocols with enhanced alarm configurations, including the introduction of a \">Abs\" alert, adjustment of prozone detection parameters, and the implementation of correlation checks between lipemic indices and triglyceride values within the laboratory information system. These practical interventions, which can be adopted in clinical laboratories, represent a proactive approach to prevent erroneous reporting and enhance diagnostic reliability. This report highlights the necessity for increased vigilance among laboratory professionals when discordance occurs between high lipemic indices and unexpectedly low triglyceride results, suggesting possible kinetic anomalies.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"36 1","pages":"011002"},"PeriodicalIF":1.8,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12912735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146222690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The hormonal interplay between the mother and the fetal-placental unit may influence the mode of delivery. This study aimed to investigate the association between maternal peripartal serum concentrations of sex hormone-binding globulin (SHBG) and 10 steroid hormones with delivery outcomes.
Materials and methods: This observational study included 171 healthy pregnant women with spontaneous onset of labor: 117 had vaginal delivery and 54 underwent urgent cesarean section (C-section). Serum concentrations of aldosterone, androstenedione, cortisol, cortisone, corticosterone, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), 17-hydroxyprogesterone, progesterone, and total testosterone were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS), while free testosterone was calculated. Sex hormone-binding globulin was measured by chemiluminescent microparticle immunoassay. Group differences were tested with the Mann-Whitney U test, and associations with delivery mode were assessed by logistic regression and receiver operating characteristic (ROC) analysis.
Results: Compared with the vaginal delivery group, women who underwent urgent C-section had significantly lower serum concentrations of SHBG, corticosterone, cortisol, aldosterone, progesterone, 17-hydroxyprogesterone, DHEA, DHEAS, and free testosterone (all P < 0.001). In multivariate logistic regression, aldosterone (odds ratio, OR 0.11, 95% CI 0.04 to 0.27, P < 0.001) and DHEAS (OR 0.74, 95% CI 0.58 to 0.94, P = 0.011) were independently associated with delivery mode. ROC analysis showed that aldosterone > 0.9 nmol/L predicted vaginal delivery with AUC 0.874, sensitivity 88%, and specificity 77%.
Conclusions: Low maternal aldosterone concentrations showed the strongest association with urgent C-section, suggesting that aldosterone may play a protective role in successful vaginal delivery.
母体和胎儿-胎盘之间的激素相互作用可能影响分娩方式。本研究旨在探讨产妇围产期血清性激素结合球蛋白(SHBG)和10种类固醇激素浓度与分娩结局的关系。材料和方法:本观察性研究纳入171例自然分娩的健康孕妇:117例阴道分娩,54例紧急剖宫产。采用液相色谱-串联质谱法(LC-MS/MS)测定血清醛固酮、雄烯二酮、皮质醇、可的松、皮质酮、脱氢表雄酮(DHEA)、硫酸脱氢表雄酮(DHEAS)、17-羟孕酮、孕酮和总睾酮浓度,计算游离睾酮浓度。化学发光微粒免疫法测定性激素结合球蛋白。采用Mann-Whitney U检验检验组间差异,采用logistic回归和受试者工作特征(ROC)分析评估与分娩方式的相关性。结果:与阴道分娩组相比,紧急剖腹产组的SHBG、皮质酮、皮质醇、醛固酮、孕酮、17-羟孕酮、DHEA、DHEAS和游离睾酮浓度显著降低(P均< 0.001)。在多因素logistic回归中,醛固酮(比值比,OR 0.11, 95% CI 0.04 ~ 0.27, P < 0.001)和DHEAS(比值比,OR 0.74, 95% CI 0.58 ~ 0.94, P = 0.011)与分娩方式独立相关。ROC分析显示,醛固酮> 0.9 nmol/L预测阴道分娩AUC 0.874,敏感性88%,特异性77%。结论:产妇醛固酮浓度低与紧急剖腹产的相关性最强,提示醛固酮可能对阴道分娩的成功起到保护作用。
{"title":"Maternal serum steroid hormones in vaginal delivery and caesarean section.","authors":"Mirta Kadivnik, Dario Mandić, Jasenka Wagner, Kristina Kralik, Siniša Šijanović, Deni Plečko, Adrijana Muller, Gramos Begolli, Željko Debeljak","doi":"10.11613/BM.2026.010705","DOIUrl":"10.11613/BM.2026.010705","url":null,"abstract":"<p><strong>Introduction: </strong>The hormonal interplay between the mother and the fetal-placental unit may influence the mode of delivery. This study aimed to investigate the association between maternal peripartal serum concentrations of sex hormone-binding globulin (SHBG) and 10 steroid hormones with delivery outcomes.</p><p><strong>Materials and methods: </strong>This observational study included 171 healthy pregnant women with spontaneous onset of labor: 117 had vaginal delivery and 54 underwent urgent cesarean section (C-section). Serum concentrations of aldosterone, androstenedione, cortisol, cortisone, corticosterone, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), 17-hydroxyprogesterone, progesterone, and total testosterone were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS), while free testosterone was calculated. Sex hormone-binding globulin was measured by chemiluminescent microparticle immunoassay. Group differences were tested with the Mann-Whitney U test, and associations with delivery mode were assessed by logistic regression and receiver operating characteristic (ROC) analysis.</p><p><strong>Results: </strong>Compared with the vaginal delivery group, women who underwent urgent C-section had significantly lower serum concentrations of SHBG, corticosterone, cortisol, aldosterone, progesterone, 17-hydroxyprogesterone, DHEA, DHEAS, and free testosterone (all P < 0.001). In multivariate logistic regression, aldosterone (odds ratio, OR 0.11, 95% CI 0.04 to 0.27, P < 0.001) and DHEAS (OR 0.74, 95% CI 0.58 to 0.94, P = 0.011) were independently associated with delivery mode. ROC analysis showed that aldosterone > 0.9 nmol/L predicted vaginal delivery with AUC 0.874, sensitivity 88%, and specificity 77%.</p><p><strong>Conclusions: </strong>Low maternal aldosterone concentrations showed the strongest association with urgent C-section, suggesting that aldosterone may play a protective role in successful vaginal delivery.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"36 1","pages":"010705"},"PeriodicalIF":1.8,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-15Epub Date: 2025-12-15DOI: 10.11613/BM.2026.010502
Yasmine Bendimrad, Lamia Mellah, Malak Snoussi, Jalila El Bakkouri
Introduction: Differentiating between malignant pleural effusion (MPE) and tuberculous pleural effusion (TPE) remains challenging in clinical practice. The cancer ratio plus (CR+), a potential diagnostic tool calculated as serum lactate dehydrogenase/(pleural adenosine deaminase x pleural lymphocyte percentage) has emerged to address this diagnostic challenge. This scoping review maps the available evidence on its diagnostic performance.
Materials and methods: We conducted a systematic search of PubMed, Scopus, and Web of Science databases from inception to April 2025. Eligible studies assessed the accuracy of CR+ in distinguishing MPE from TPE. Data on study design, cut-off values, sensitivity, specificity, area under the curve (AUC), and likelihood ratios were extracted and synthesized narratively.
Results: Six studies comprising 881 patients were included. Reported cut-off values varied widely (5.7 - 41.0), as did sensitivity (74.3 - 97.6%) and specificity (36.6 - 94.1%). Most studies, however, reported good discriminatory power with AUC values generally above 0.80. The highest diagnostic accuracy was observed in one study, which reported a sensitivity of 97.6%, a specificity of 94.1%, and an AUC of 0.86. Differences in cut-off thresholds, study populations, local tuberculosis epidemiology, and laboratory methodology (particularly lymphocyte quantification) likely contributed to this heterogeneity.
Conclusions: The CR+ appears promising as a non-invasive tool using routine parameters for differentiating MPE from TPE, but diagnostic performance varies across settings. The heterogeneity in optimal cut-off values highlights the need for local validation before clinical adoption. Future research should standardize methodology and assess its impact on decision-making and patient outcomes.
在临床实践中,鉴别恶性胸腔积液(MPE)和结核性胸腔积液(TPE)仍然具有挑战性。癌症比率加(CR+)是一种潜在的诊断工具,通过计算血清乳酸脱氢酶/(胸膜腺苷脱氨酶x胸膜淋巴细胞百分比)来解决这一诊断挑战。这一范围审查绘制了有关其诊断性能的现有证据。材料和方法:我们对PubMed、Scopus和Web of Science数据库进行了系统的检索,检索时间从成立到2025年4月。合格的研究评估了CR+在区分MPE和TPE方面的准确性。对研究设计、临界值、敏感性、特异性、曲线下面积(AUC)和似然比等数据进行提取和综合。结果:纳入6项研究,共881例患者。报道的临界值差异很大(5.7 - 41.0),敏感性(74.3 - 97.6%)和特异性(36.6 - 94.1%)也是如此。然而,大多数研究报道了良好的鉴别力,AUC值一般在0.80以上。在一项研究中观察到最高的诊断准确性,其敏感性为97.6%,特异性为94.1%,AUC为0.86。截止阈值、研究人群、当地结核病流行病学和实验室方法(特别是淋巴细胞定量)的差异可能导致这种异质性。结论:CR+似乎有望作为一种非侵入性工具,使用常规参数来区分MPE和TPE,但诊断性能因设置而异。最佳临界值的异质性突出了在临床采用前需要进行局部验证。未来的研究应使方法标准化,并评估其对决策和患者预后的影响。
{"title":"The cancer ratio plus in the differential diagnosis of pleural effusions: a scoping review of current evidence.","authors":"Yasmine Bendimrad, Lamia Mellah, Malak Snoussi, Jalila El Bakkouri","doi":"10.11613/BM.2026.010502","DOIUrl":"10.11613/BM.2026.010502","url":null,"abstract":"<p><strong>Introduction: </strong>Differentiating between malignant pleural effusion (MPE) and tuberculous pleural effusion (TPE) remains challenging in clinical practice. The cancer ratio plus (CR+), a potential diagnostic tool calculated as serum lactate dehydrogenase/(pleural adenosine deaminase x pleural lymphocyte percentage) has emerged to address this diagnostic challenge. This scoping review maps the available evidence on its diagnostic performance.</p><p><strong>Materials and methods: </strong>We conducted a systematic search of PubMed, Scopus, and Web of Science databases from inception to April 2025. Eligible studies assessed the accuracy of CR+ in distinguishing MPE from TPE. Data on study design, cut-off values, sensitivity, specificity, area under the curve (AUC), and likelihood ratios were extracted and synthesized narratively.</p><p><strong>Results: </strong>Six studies comprising 881 patients were included. Reported cut-off values varied widely (5.7 - 41.0), as did sensitivity (74.3 - 97.6%) and specificity (36.6 - 94.1%). Most studies, however, reported good discriminatory power with AUC values generally above 0.80. The highest diagnostic accuracy was observed in one study, which reported a sensitivity of 97.6%, a specificity of 94.1%, and an AUC of 0.86. Differences in cut-off thresholds, study populations, local tuberculosis epidemiology, and laboratory methodology (particularly lymphocyte quantification) likely contributed to this heterogeneity.</p><p><strong>Conclusions: </strong>The CR+ appears promising as a non-invasive tool using routine parameters for differentiating MPE from TPE, but diagnostic performance varies across settings. The heterogeneity in optimal cut-off values highlights the need for local validation before clinical adoption. Future research should standardize methodology and assess its impact on decision-making and patient outcomes.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"36 1","pages":"010502"},"PeriodicalIF":1.8,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Cardiac biomarkers may help diagnose and monitor different neonatal conditions, but their concentrations are still underexplored in common pathologies diagnosed within the first day. This study compared N-terminal pro b-type natriuretic peptide (NT-proBNP), high sensitivity troponin I (hs-TnI), creatine kinase (CK), and its isoenzyme creatine kinase-myocardial band (CK-MB) concentrations and activities, measured within the first 24 hours (h) postpartum, between the healthy term neonates and those with jaundice, perinatal infection, transient neurological abnormalities (TNA), and heart ultrasound abnormalities.
Materials and methods: The study included 100 term newborns, whose cardiac biomarkers' concentrations were determined from the serum within 24 h postpartum on the Alinity ci analyzer (Abbott, Chicago, USA). The Mann-Whitney and Kruskal-Wallis tests, performed in SPSS Statistics v. 25.0 (IBM Corp., Armonk, USA), were used to test the significance of differences between the study groups, with P < 0.05 indicating significance.
Results: Within first 24 h postpartum healthy newborns had significantly higher CK activities compared to those with jaundice (P = 0.047), perinatal infection (P = 0.012), or combination of both (P = 0.017). Lower CK activities were demonstrated in perinatal infection compared to TNA (P = 0.041). Other biomarkers' concentrations did not differ between the study groups. No significant differences were found in cardiac biomarkers' concentrations regarding gender or heart ultrasound findings.
Conclusions: During the first 24 h postpartum, only CK activities differed between healthy newborns and those with the common pathologic conditions, being lower in the newborns with jaundice and/or infection. Analogous differences were present between newborns with infection and those with TNA.
{"title":"Cardiac biomarkers in term newborns with common pathological conditions during the first 24 hours postpartum.","authors":"Helena Karlović, Marjana Jerković Raguž, Ivanka Mikulić, Vinka Mikulić, Vajdana Tomić","doi":"10.11613/BM.2025.030702","DOIUrl":"10.11613/BM.2025.030702","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiac biomarkers may help diagnose and monitor different neonatal conditions, but their concentrations are still underexplored in common pathologies diagnosed within the first day. This study compared N-terminal pro b-type natriuretic peptide (NT-proBNP), high sensitivity troponin I (hs-TnI), creatine kinase (CK), and its isoenzyme creatine kinase-myocardial band (CK-MB) concentrations and activities, measured within the first 24 hours (h) postpartum, between the healthy term neonates and those with jaundice, perinatal infection, transient neurological abnormalities (TNA), and heart ultrasound abnormalities.</p><p><strong>Materials and methods: </strong>The study included 100 term newborns, whose cardiac biomarkers' concentrations were determined from the serum within 24 h postpartum on the Alinity ci analyzer (Abbott, Chicago, USA). The Mann-Whitney and Kruskal-Wallis tests, performed in SPSS Statistics v. 25.0 (IBM Corp., Armonk, USA), were used to test the significance of differences between the study groups, with P < 0.05 indicating significance.</p><p><strong>Results: </strong>Within first 24 h postpartum healthy newborns had significantly higher CK activities compared to those with jaundice (P = 0.047), perinatal infection (P = 0.012), or combination of both (P = 0.017). Lower CK activities were demonstrated in perinatal infection compared to TNA (P = 0.041). Other biomarkers' concentrations did not differ between the study groups. No significant differences were found in cardiac biomarkers' concentrations regarding gender or heart ultrasound findings.</p><p><strong>Conclusions: </strong>During the first 24 h postpartum, only CK activities differed between healthy newborns and those with the common pathologic conditions, being lower in the newborns with jaundice and/or infection. Analogous differences were present between newborns with infection and those with TNA.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"35 3","pages":"030702"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12334941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144877697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-15Epub Date: 2025-08-15DOI: 10.11613/BM.2025.031001
Tomáš Šálek, Pavel Musil, Irena Zlatníková
This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 °C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making.
{"title":"What is uric acid concentration in urine in patients with uric acid kidney stones? - a case study.","authors":"Tomáš Šálek, Pavel Musil, Irena Zlatníková","doi":"10.11613/BM.2025.031001","DOIUrl":"10.11613/BM.2025.031001","url":null,"abstract":"<p><p>This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 °C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"35 3","pages":"031001"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12334940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144877711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lea Gvozdanović, Željka Dragila, Luka Maršić, Denis Klapan, Željka Dujmić, Josip Samardžić, Zrinka Mihaljević, Višnja Nesek-Adam
Acute abdominal pain accounts for 7-10% of all emergency department visits. Appendicitis, being one of the leading causes of acute abdominal surgery, poses significant diagnostic challenges. Negative appendectomy rates can be as high as 40%, while complications occur in more than 90% if the diagnosis is missed during the initial examination. Therefore, more effective preoperative screening is required for patients with suspected appendicitis. Recent studies suggest that novel biomarkers, particularly leucine-rich alpha 2-glycoprotein and calprotectin, may improve the early and accurate diagnosis of acute appendicitis by demonstrating high specificity and sensitivity, respectively. Unlike C-reactive protein, the production of leucine-rich alpha 2-glycoprotein 1 and calprotectin takes place at the site of inflammation. As a result, their raised concentrations might be evident early in a disease, possibly before other common markers of inflammation start to rise. This literature review aims to assess the potential role of leucine-rich alpha 2-glycoprotein 1 and calprotectin as diagnostic biomarkers in patients with suspected acute appendicitis, acknowledging the need for additional data to fully assess their diagnostic accuracy.
{"title":"Diagnostic value of leucine-rich alpha-2-glycoprotein 1 and calprotectin in acute appendicitis: a short review.","authors":"Lea Gvozdanović, Željka Dragila, Luka Maršić, Denis Klapan, Željka Dujmić, Josip Samardžić, Zrinka Mihaljević, Višnja Nesek-Adam","doi":"10.11613/BM.2025.030504","DOIUrl":"10.11613/BM.2025.030504","url":null,"abstract":"<p><p>Acute abdominal pain accounts for 7-10% of all emergency department visits. Appendicitis, being one of the leading causes of acute abdominal surgery, poses significant diagnostic challenges. Negative appendectomy rates can be as high as 40%, while complications occur in more than 90% if the diagnosis is missed during the initial examination. Therefore, more effective preoperative screening is required for patients with suspected appendicitis. Recent studies suggest that novel biomarkers, particularly leucine-rich alpha 2-glycoprotein and calprotectin, may improve the early and accurate diagnosis of acute appendicitis by demonstrating high specificity and sensitivity, respectively. Unlike C-reactive protein, the production of leucine-rich alpha 2-glycoprotein 1 and calprotectin takes place at the site of inflammation. As a result, their raised concentrations might be evident early in a disease, possibly before other common markers of inflammation start to rise. This literature review aims to assess the potential role of leucine-rich alpha 2-glycoprotein 1 and calprotectin as diagnostic biomarkers in patients with suspected acute appendicitis, acknowledging the need for additional data to fully assess their diagnostic accuracy.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"35 3","pages":"030504"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523658/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adriana Bokulić, Ivana Zec, Domagoj Marijančević, Marija Siter Kuprešanin, Sanja Goreta, Anamarija Đuras, Koraljka Đurić, Sanda Jelisavac Ćosić, Iva Lukić, Tihana Serdar Hiršl, Lada Stanišić, Daniela Šupe-Domić, Alenka Pezo, Marija Kocijančić
Thyroid function tests (TFTs) - thyroid stimulating hormone (TSH), total triiodothyronine (T3), total thyroxine (T4), free triiodothyronine (FT3), free thyroxine (FT4), thyroid peroxidase antibodies (anti-TPO), thyroglobulin antibodies (anti-Tg), TSH receptors antibodies (anti-TSHR), and thyroglobulin (Tg) - are used to diagnose thyroid disorders and are crucial biomarkers for monitoring and managing thyroid cancer. The 2022 national survey results revealed that thyroid function testing is not standardized among Croatian medical-biochemistry laboratories. Laboratories follow individual protocols at each testing stage, from patient preparation to result reporting. To address this, the Working group for laboratory endocrinology of the Croatian society of medical biochemistry and laboratory medicine has developed recommendations based on the latest national and international guidelines, research and the authors' expert opinion. The document aims to standardize all phases of thyroid function testing, with 7 preanalytical, 12 analytical, and 8 postanalytical recommendations, each supported by expert explanations. While primarily directed at Croatian laboratory professionals, this document is also relevant to other healthcare professionals managing thyroid-related health issues.
{"title":"National recommendations of the Croatian society of medical biochemistry and laboratory medicine: Thyroid function tests from the laboratory point of view.","authors":"Adriana Bokulić, Ivana Zec, Domagoj Marijančević, Marija Siter Kuprešanin, Sanja Goreta, Anamarija Đuras, Koraljka Đurić, Sanda Jelisavac Ćosić, Iva Lukić, Tihana Serdar Hiršl, Lada Stanišić, Daniela Šupe-Domić, Alenka Pezo, Marija Kocijančić","doi":"10.11613/BM.2025.030505","DOIUrl":"10.11613/BM.2025.030505","url":null,"abstract":"<p><p>Thyroid function tests (TFTs) - thyroid stimulating hormone (TSH), total triiodothyronine (T3), total thyroxine (T4), free triiodothyronine (FT3), free thyroxine (FT4), thyroid peroxidase antibodies (anti-TPO), thyroglobulin antibodies (anti-Tg), TSH receptors antibodies (anti-TSHR), and thyroglobulin (Tg) - are used to diagnose thyroid disorders and are crucial biomarkers for monitoring and managing thyroid cancer. The 2022 national survey results revealed that thyroid function testing is not standardized among Croatian medical-biochemistry laboratories. Laboratories follow individual protocols at each testing stage, from patient preparation to result reporting. To address this, the Working group for laboratory endocrinology of the Croatian society of medical biochemistry and laboratory medicine has developed recommendations based on the latest national and international guidelines, research and the authors' expert opinion. The document aims to standardize all phases of thyroid function testing, with 7 preanalytical, 12 analytical, and 8 postanalytical recommendations, each supported by expert explanations. While primarily directed at Croatian laboratory professionals, this document is also relevant to other healthcare professionals managing thyroid-related health issues.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"35 3","pages":"030505"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Hepcidin (Hep), a key regulatory hormone of iron (Fe) homeostasis, governs its absorption and storage, and is influenced by inflammation and Fe status. This study investigated serum Hep concentrations and their associations with Fe markers and inflammation in patients with sporadic colorectal cancer (CRC).
Materials and methods: We compared serum concentrations of Hep, Fe, unsaturated and total iron binding capacity, transferrin, transferrin saturation, ferritin, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor markers in 82 CRC patients and 58 controls. Statistically significant differences were tested using the Mann-Whitney U test and Student's t test. Additionally, Hep were analyzed according to tumor stage. Colorectal cancer was confirmed histopathologically after colonoscopy with biopsy (TNM staging).
Results: Colorectal cancer patients exhibited significantly lower Hep concentrations than controls (8.1 vs. 19.7 ng/mL, P = 0.020). Ferritin was also lower in CRC (109 vs. 250 µg/L, P = 0.002). Hepcidin showed the strongest positive correlation with ferritin in CRC. Inflammatory markers (CRP and IL-6) correlated moderately to weakly with hepcidin in both groups (controls: rho = 0.52 (P < 0.001); CRC: rho = 0.26 (P = 0.022) for CRP and CRC: rho = 0.30 (P = 0.033) for IL-6). Notably, Hep concentrations were lower in patients with advanced tumor stage (T0 vs. T3, P = 0.043).
Conclusion: These findings suggest that CRC is associated with lower hepcidin and ferritin concentrations, potentially reflecting complex and cancer-specific dysregulation in Fe metabolism beyond inflammation alone.
Hepcidin (Hep)是铁(Fe)体内平衡的关键调节激素,控制铁(Fe)的吸收和储存,并受炎症和铁状态的影响。本研究探讨散发性结直肠癌(CRC)患者血清Hep浓度及其与铁标志物和炎症的关系。材料与方法:我们比较了82例结直肠癌患者和58例对照者血清Hep、Fe、不饱和铁和总铁结合能力、转铁蛋白、转铁蛋白饱和度、铁蛋白、c反应蛋白(CRP)、白细胞介素-6 (IL-6)和肿瘤标志物的浓度。采用Mann-Whitney U检验和Student’st检验检验统计学显著性差异。并根据肿瘤分期分析Hep。结肠镜活检(TNM分期)后病理证实为结直肠癌。结果:结直肠癌患者的Hep浓度明显低于对照组(8.1 vs. 19.7 ng/mL, P = 0.020)。铁蛋白在结直肠癌中也较低(109 vs 250µg/L, P = 0.002)。Hepcidin与铁蛋白在结直肠癌中表现出最强的正相关。两组炎症标志物(CRP和IL-6)与hepcidin有中至弱相关性(对照组:rho = 0.52 (P < 0.001);CRC: rho = 0.26 (P = 0.022), CRC: rho = 0.30 (P = 0.033)。值得注意的是,晚期肿瘤患者的Hep浓度较低(T0 vs. T3, P = 0.043)。结论:这些发现表明,结直肠癌与较低的hepcidin和铁蛋白浓度有关,可能反映了除了炎症之外铁代谢的复杂和癌症特异性失调。
{"title":"Serum hepcidin concentration is lower in advanced stages of sporadic colorectal cancer.","authors":"Tara Rolić, Sanja Mandić, Mazyar Yazdani, Marina Ferenac Kiš, Sonia Distante, Ines Banjari","doi":"10.11613/BM.2025.030703","DOIUrl":"10.11613/BM.2025.030703","url":null,"abstract":"<p><strong>Introduction: </strong>Hepcidin (Hep), a key regulatory hormone of iron (Fe) homeostasis, governs its absorption and storage, and is influenced by inflammation and Fe status. This study investigated serum Hep concentrations and their associations with Fe markers and inflammation in patients with sporadic colorectal cancer (CRC).</p><p><strong>Materials and methods: </strong>We compared serum concentrations of Hep, Fe, unsaturated and total iron binding capacity, transferrin, transferrin saturation, ferritin, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor markers in 82 CRC patients and 58 controls. Statistically significant differences were tested using the Mann-Whitney U test and Student's t test. Additionally, Hep were analyzed according to tumor stage. Colorectal cancer was confirmed histopathologically after colonoscopy with biopsy (TNM staging).</p><p><strong>Results: </strong>Colorectal cancer patients exhibited significantly lower Hep concentrations than controls (8.1 <i>vs</i>. 19.7 ng/mL, P = 0.020). Ferritin was also lower in CRC (109 <i>vs</i>. 250 µg/L, P = 0.002). Hepcidin showed the strongest positive correlation with ferritin in CRC. Inflammatory markers (CRP and IL-6) correlated moderately to weakly with hepcidin in both groups (controls: rho = 0.52 (P < 0.001); CRC: rho = 0.26 (P = 0.022) for CRP and CRC: rho = 0.30 (P = 0.033) for IL-6). Notably, Hep concentrations were lower in patients with advanced tumor stage (T0 <i>vs</i>. T3, P = 0.043).</p><p><strong>Conclusion: </strong>These findings suggest that CRC is associated with lower hepcidin and ferritin concentrations, potentially reflecting complex and cancer-specific dysregulation in Fe metabolism beyond inflammation alone.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"35 3","pages":"030703"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Atherosclerosis is an active interaction between lipoproteins and inflammatory cells. Monocytes and macrophages are the most important immune cells involved in the process of atherosclerosis. They interact with atherogenic lipoproteins, in particular low density lipoprotein (LDL) cholesterol and lipoprotein(a) (Lp(a)). The increased concentration of the LDL cholesterol and Lp(a) accelerates the polarization of monocytes and macrophages toward proinflammatory phenotype and the formation of the foam cells. These cells then release large quantities of inflammatory cytokines that stimulate the oxidation of atherogenic lipoproteins that are even more atherogenic and contribute to the formation of foam cells and the secretion of the pro-inflammatory cytokines, thus creating a vicious circle. Surface marker C-C chemokine receptor type 2, expressed on monocytes/macrophages, enables their adhesion and migration into the subendothelial layer. The rupture of the atherosclerotic plaque on one hand, and the ability of the oxidized LDL cholesterol and Lp(a) to trigger arterial thrombosis by different mechanisms on the other hand, result in acute cardiovascular event. Here, we summarize the role of the monocytes and macrophages in atherosclerosis and explore the influence of LDL cholesterol and Lp(a) on monocytes and macrophages during the entire process of atherosclerosis, from its initiation to progression.
{"title":"Influence of LDL cholesterol and Lp(a) on monocytes and macrophages in atherosclerosis.","authors":"Sabina Ugovšek, Jernej Jeras, Miran Šebeštjen, Janja Zupan","doi":"10.11613/BM.2025.030503","DOIUrl":"10.11613/BM.2025.030503","url":null,"abstract":"<p><p>Atherosclerosis is an active interaction between lipoproteins and inflammatory cells. Monocytes and macrophages are the most important immune cells involved in the process of atherosclerosis. They interact with atherogenic lipoproteins, in particular low density lipoprotein (LDL) cholesterol and lipoprotein(a) (Lp(a)). The increased concentration of the LDL cholesterol and Lp(a) accelerates the polarization of monocytes and macrophages toward proinflammatory phenotype and the formation of the foam cells. These cells then release large quantities of inflammatory cytokines that stimulate the oxidation of atherogenic lipoproteins that are even more atherogenic and contribute to the formation of foam cells and the secretion of the pro-inflammatory cytokines, thus creating a vicious circle. Surface marker C-C chemokine receptor type 2, expressed on monocytes/macrophages, enables their adhesion and migration into the subendothelial layer. The rupture of the atherosclerotic plaque on one hand, and the ability of the oxidized LDL cholesterol and Lp(a) to trigger arterial thrombosis by different mechanisms on the other hand, result in acute cardiovascular event. Here, we summarize the role of the monocytes and macrophages in atherosclerosis and explore the influence of LDL cholesterol and Lp(a) on monocytes and macrophages during the entire process of atherosclerosis, from its initiation to progression.</p>","PeriodicalId":94370,"journal":{"name":"Biochemia medica","volume":"35 3","pages":"030503"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}